ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure.

Philippe Armand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.